
Nectar Lifescience Ltd
NSE: NECLIFE BSE: 532649
₹13.87
(3.97)%
Mon, 02 Feb 2026, 04:40 pm
Market Cap3.01B
PE Ratio-
Dividend0
Ratios
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 9.47 | 6.50 | 5.59 | 4.45 | 8.44 | 5.20 | 7.35 | 4.10 | 8.74 | 12.51 | 15.70 | 14.25 | 11.35 | 8.06 | 6.98 | 0 | 21.53 | 0 | 135.20 | 0 |
| Price to book ratio | 1.99 | 0.97 | 1.08 | 0.57 | 1.31 | 0.74 | 0.69 | 0.40 | 0.59 | 0.86 | 0.89 | 0.78 | 0 | 0.35 | 0.20 | 0.39 | 0.50 | 0.33 | 0.63 | 0.54 |
| Price to sales ratio | 1.39 | 0.68 | 0.57 | 0.32 | 0.93 | 0.51 | 0.41 | 0.22 | 0.33 | 0.50 | 0.51 | 0.48 | 0.32 | 0.14 | 0.09 | 0.27 | 0.32 | 0.23 | 0.40 | 0.31 |
| Price to cash flow ratio | 0 | 45.65 | 2.78 | 2.25 | 0 | 0 | 7.20 | 1.34 | 4.22 | 21.39 | 16.66 | 8.96 | 0 | 3.95 | 1.37 | 0 | 29.83 | 6.36 | 4.50 | 5.35 |
| Enterprise value | 4.98B | 6.81B | 8.77B | 9.05B | 13.51B | 12.99B | 15.56B | 12.24B | 13.91B | 17.18B | 17.77B | 16.54B | 15.38B | 12.65B | 9.79B | 12.95B | 13.81B | 10.92B | 12.9B | 10.78B |
| Enterprise value to EBITDA ratio | 8.18 | 8.42 | 6.92 | 6.40 | 6.88 | 5.80 | 6.79 | 4.22 | 4.83 | 6.46 | 7.40 | 7.32 | 6.46 | 4.74 | 4.41 | 11.62 | 8.67 | 19.84 | 8.35 | 0 |
| Debt to equity ratio | 0.84 | 1.91 | 1.71 | 2.32 | 0.97 | 1.10 | 1.33 | 1.01 | 0.93 | 0.97 | 1.01 | 0.87 | 0.90 | 0.82 | 0.69 | 0.85 | 0.79 | 0.71 | 0.59 | 0.61 |
| Return on equity % | 28.26 | 21.69 | 29.61 | 18.04 | 19.98 | 15.37 | 9.73 | 10.38 | 6.92 | 7.03 | 5.67 | 5.64 | 5.06 | 4.40 | 2.84 | -6.67 | 2.33 | -2.25 | 0.47 | -11.23 |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800